| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.584 | 6.275 | 3.427 | 10.639 | 20.134 | 16.201 | 39.641 | 28.312 | 44.474 | 37.047 |
| Total Income - EUR | 7.584 | 6.275 | 3.427 | 10.639 | 20.134 | 16.201 | 39.641 | 28.312 | 97.906 | 39.685 |
| Total Expenses - EUR | 5.998 | 7.228 | 2.917 | 3.538 | 1.607 | 1.998 | 1.721 | 1.598 | 50.984 | 13.434 |
| Gross Profit/Loss - EUR | 1.587 | -952 | 510 | 7.101 | 18.527 | 14.202 | 37.920 | 26.714 | 46.922 | 26.251 |
| Net Profit/Loss - EUR | 1.359 | -1.141 | -157 | 6.782 | 17.923 | 13.755 | 36.754 | 25.944 | 46.060 | 25.862 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ampro Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 58.155 | 56.635 | 53.862 | 51.202 | 48.789 | 46.470 | 44.077 | 42.846 | 0 | 0 |
| Current Assets | 3.848 | 2.564 | 5.509 | 14.151 | 33.193 | 33.178 | 53.364 | 67.544 | 89.920 | 95.012 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 223 | 176 | 2.880 | 136 | 71 | 289 | 101 | 233 | 3.624 | 3.107 |
| Cash | 3.625 | 2.388 | 2.629 | 14.015 | 33.122 | 32.890 | 53.263 | 67.311 | 25.647 | 8.114 |
| Shareholders Funds | 24.800 | 23.406 | 22.853 | 29.216 | 46.573 | 44.973 | 80.730 | 29.869 | 75.838 | 41.185 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 37.476 | 35.793 | 36.517 | 36.138 | 35.409 | 34.676 | 16.710 | 80.521 | 14.082 | 53.827 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ampro Med Srl